Abstract
The GTI QuikScreen test is an enzyme-linked immunosorbent assay (ELISA) that uses soluble HLA class I antigens as targets. In tests of 5,893 human serum specimens, we evaluated the reliability, sensitivity, and utility of the GTI QuikScreen test for detecting HLA class I-specific antibody. We found that the test could reliably detect HLA-specific antibodies of the immunoglobulin G (IgG) but not the IgM class. The degree of correlation with lymphocytotoxicity testing varied among the different serum sources, with the best correlation achieved with sera from renal transplant candidates (r > 0.7) and the poorest with sera from patients with end-stage liver disease (r = 0.26), possibly because of elevated alkaline phosphatase levels in the liver patients. Test reproducibility was high (96%), and test failure rate was low (1.7%). The test sensitivity is comparable to that of the antiglobulin cytotoxicity and, possibly, even flow cytometric tests. There was a highly significant (P < 0.001) correlation between the optical densities obtained in the ELISA and the percent panel reactive antibody determined by cytotoxicity testing. Therefore, although designed only to determine the presence or absence of HLA-specific antibody, GTI QuikScreen test results also provided an indication of the extent of sensitization. The test is one of the most effective and efficient ways to determine if antibodies producing a positive result in crossmatch tests are specific for HLA class I antigens. As an adjunct to serum screening by cytotoxicity testing, the GTI QuikScreen test can produce a substantial savings of time and effort that reduces the cost to the laboratory and to the patient.
Full Text
The Full Text of this article is available as a PDF (238.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bray R. A. Flow cytometry in the transplant laboratory. Ann N Y Acad Sci. 1993 Mar 20;677:138–151. doi: 10.1111/j.1749-6632.1993.tb38772.x. [DOI] [PubMed] [Google Scholar]
- Doxiadis I., Westhoff U., Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut. 1989 Nov;59(5):449–454. doi: 10.1007/BF00349066. [DOI] [PubMed] [Google Scholar]
- Fuller T. C. Monitoring HLA alloimmunization. Analysis of HLA alloantibodies in the serum of prospective transplant recipients. Clin Lab Med. 1991 Sep;11(3):551–570. [PubMed] [Google Scholar]
- Kao K. J., Scornik J. C., Small S. J. Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity. Transplantation. 1993 Jan;55(1):192–196. doi: 10.1097/00007890-199301000-00036. [DOI] [PubMed] [Google Scholar]
- Mueller-Eckhardt G., Hauck M., Kayser W., Mueller-Eckhardt C. HLA--C antigens on platelets. Tissue Antigens. 1980 Jul;16(1):91–94. [PubMed] [Google Scholar]
- Pouletty C., Mercier I., Glanville L., Tomavo N., Igoudin L., Pouletty P., Buelow R. Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay. Hum Immunol. 1994 Jul;40(3):218–227. doi: 10.1016/0198-8859(94)90072-8. [DOI] [PubMed] [Google Scholar]
- Rodey G. E., Neylan J. F., Whelchel J. D., Revels K. W., Bray R. A. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol. 1994 Apr;39(4):272–280. doi: 10.1016/0198-8859(94)90270-4. [DOI] [PubMed] [Google Scholar]
- Shroyer T. W., Deierhoi M. H., Mink C. A., Cagle L. R., Hudson S. L., Rhea S. D., Diethelm A. G. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups. Transplantation. 1995 Feb 27;59(4):626–630. [PubMed] [Google Scholar]
- Zachary A. A., Braun W. E. Calculation of a predictive value for transplantation. Transplantation. 1985 Mar;39(3):316–318. doi: 10.1097/00007890-198503000-00024. [DOI] [PubMed] [Google Scholar]
- Zachary A. A., Steinberg A. G., Bias W. B., Leffell M. S. The frequencies of HLA alleles and haplotypes and their distribution among donors and renal patients in the UNOS registry. Transplantation. 1996 Jul 27;62(2):272–283. doi: 10.1097/00007890-199607270-00021. [DOI] [PubMed] [Google Scholar]